The Australian Technical Advisory Group on Immunisation (ATAGI) recently released advice about COVID-19 booster dose for specified groups as follows:
ATAGI advice recommends a 2023 COVID-19 vaccine booster dose for adults in the following groups, if their last COVID-19 vaccine dose or confirmed infection (whichever is the most recent) was 6 months ago or longer, and regardless of the number of prior doses received:
ATAGI advises the following groups should consider a 2023 booster dose if their last COVID-19 vaccine dose or confirmed infection (whichever is the most recent) was 6 months ago or longer, and regardless of the number of prior doses received, based on an individual risk benefit assessment with their immunisation provider.
Serious adverse events following immunisation (AEFI) are notifiable conditions in NSW. Healthcare providers are required to report any serious AEFI to NSW Health and the Therapeutic Goods Administration. More information is available on Adverse events following immunisation (AEFI).
Training modules are available for clinical staff including: